# Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts
Canonical URL: https://biopharmsignal.com/news/DCTH/delcath-systems-announces-two-asco-2026-investigator-initiated-trials-in-progress-abstracts
Ticker: DCTH
Company: Delcath Systems
Source: Delcath Systems
Published: 2026-06-25 13:46 EST
Original Source URL: https://delcathsystemsinc.gcs-web.com
## Summary

QUEENSBURY, N.Y. --(BUSINESS WIRE)--May 26, 2026-- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced the publication of two investigator-initiated trials-in-progress abstracts on May 21,

## Article Body
QUEENSBURY, N.Y. --(BUSINESS WIRE)--May 26, 2026-- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced the publication of two investigator-initiated trials-in-progress abstracts on May 21,
## Recent Company News
- 2026-06-25 13:46 EST — [Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts](https://biopharmsignal.com/news/DCTH/delcath-systems-announces-two-asco-2026-investigator-initiated-trials-in-progress-abstracts) — Source: Delcath Systems
- 2026-06-25 13:46 EST — [Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference](https://biopharmsignal.com/news/DCTH/delcath-systems-to-participate-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference) — Source: Delcath Systems
- 2026-06-25 13:46 EST — [Delcath Systems Reports First Quarter 2026 Results and Business Highlights](https://biopharmsignal.com/news/DCTH/delcath-systems-reports-first-quarter-2026-results-and-business-highlights) — Source: Delcath Systems
- 2026-06-25 13:46 EST — [Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026](https://biopharmsignal.com/news/DCTH/delcath-systems-announces-presentation-of-new-data-on-percutaneous-hepatic-perfusion-with-melphalan-in-liver-dominant-metastatic-breast-cancer-at-esmo-breast-cancer-2026) — Source: Delcath Systems
- 2026-06-25 13:46 EST — [Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma](https://biopharmsignal.com/news/DCTH/delcath-systems-announces-publication-of-subgroup-analyses-of-the-phase-3-focus-study-of-melphalan-hepatic-delivery-system-in-patients-with-unresectable-metastatic-uveal-melanoma) — Source: Delcath Systems
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)